KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Gross Margin (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Gross Margin for 11 consecutive years, with 28.98% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin fell 425.0% year-over-year to 28.98%, compared with a TTM value of 99.72% through Dec 2025, up 6860.0%, and an annual FY2025 reading of 30.06%, down 106.0% over the prior year.
  • Gross Margin was 28.98% for Q4 2025 at Medpace Holdings, down from 33.23% in the prior quarter.
  • Across five years, Gross Margin topped out at 33.23% in Q4 2024 and bottomed at 26.82% in Q2 2021.
  • Average Gross Margin over 5 years is 29.31%, with a median of 29.37% recorded in 2022.
  • The sharpest move saw Gross Margin skyrocketed 578bps in 2024, then plummeted -425bps in 2025.
  • Year by year, Gross Margin stood at 28.52% in 2021, then rose by 3bps to 29.37% in 2022, then dropped by -7bps to 27.45% in 2023, then rose by 21bps to 33.23% in 2024, then dropped by -13bps to 28.98% in 2025.
  • Business Quant data shows Gross Margin for MEDP at 28.98% in Q4 2025, 33.23% in Q4 2024, and 31.69% in Q3 2024.